Cover Image
市場調查報告書

美國的電生理學檢查裝置市場預測

United States Electrophysiology Devices Market Outlook to 2025

出版商 GlobalData 商品編碼 356612
出版日期 內容資訊 英文 108 Pages
訂單完成後即時交付
價格
Back to Top
美國的電生理學檢查裝置市場預測 United States Electrophysiology Devices Market Outlook to 2025
出版日期: 2018年04月09日 內容資訊: 英文 108 Pages
簡介

本報告提供美國的電生理學檢查裝置市場相關調查分析,各市場區隔的市場規模,年度的市場收益、數量、平均銷售價格,企業佔有率,流通佔有率,主要企業簡介等系統性資訊。

第1章 目錄

第2章 簡介

第3章 美國的電生理學檢查裝置市場

  • 收益成果
  • 收益預測
  • 數量成果
  • 數量預測
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第4章 美國的電生理學檢查裝置市場主要企業概要

  • Biosense Webster, Inc.
  • St. Jude Medical, Inc.
  • Medtronic plc
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG

第5章 電生理學檢查裝置市場開發中產品

第6章 財務交易形勢

  • 收購
  • 發行公司債券
  • 股票上市
  • 夥伴關係

第7章 最近的趨勢

  • 企業宣傳
  • 公佈財報
  • 政府、公益
  • 法律規章
  • 其他的重要趨勢
  • 策略、產業計畫

第8章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECC2975DB

GlobalData's new report, United States Electrophysiology Devices Market Outlook to 2025, provides key market data on the United States Electrophysiology Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments -Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters and Electrophysiology Lab Systems.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Electrophysiology Devices market segments - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters and Electrophysiology Lab Systems.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Electrophysiology Devices market.
  • Global corporate-level profiles of key companies operating within the United States Electrophysiology Devices market.
  • Key players covered include Abbott Laboratories, Medtronic plc, Biosense Webster Inc, and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 What Is This Report About? 6
  • 2.2 Electrophysiology Devices Market Segmentation 6
  • 2.3 Definitions of Markets Covered in the Report 7

3 Electrophysiology Devices Market, United States 9

  • 3.1 Electrophysiology Devices Market, United States, Revenue ($m), 2015-2025 9
    • 3.1.1 Electrophysiology Ablation Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 11
    • 3.1.2 Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 13
    • 3.1.3 Electrophysiology Lab Systems Market, United States, Revenue ($m), by Segment, 2015-2025 15
  • 3.2 Electrophysiology Devices Market, United States, Volume (Units), 2015-2025 18
    • 3.2.1 Electrophysiology Ablation Catheters Market, United States, Volume (Units), by Segment, 2015-2025 20
    • 3.2.2 Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), by Segment, 2015-2025 22
    • 3.2.3 Electrophysiology Lab Systems Market, United States, Volume (Units), by Segment, 2015-2025 24
  • 3.3 Electrophysiology Devices Market, United States, Average Price ($), 2015-2025 27
  • 3.4 Electrophysiology Devices Market, United States, Distribution Share by Revenue ($m), 2017 29
  • 3.5 Electrophysiology Devices Market, United States, Company Share by Revenue ($m), 2017 30

4 Overview of Key Companies in United States, Electrophysiology Devices Market 32

  • 4.1 Biosense Webster Inc 32
    • 4.1.1 Company Overview 32
  • 4.2 Abbott Laboratories 32
    • 4.2.1 Company Overview 32
  • 4.3 Medtronic Plc 32
    • 4.3.1 Company Overview 32
  • 4.4 Boston Scientific Corp 32
    • 4.4.1 Company Overview 32
  • 4.5 Micropace EP Inc. 33
    • 4.5.1 Company Overview 33
  • 4.6 Fischer Imaging Corp 33
    • 4.6.1 Company Overview 33

5 Electrophysiology Devices Market Pipeline Products 34

6 Financial Deals Landscape 35

  • 6.1 Acquisition 35
    • 6.1.1 NN Acquires Bridgemedica 35
    • 6.1.2 Becton, Dickinson Acquires C. R. Bard for USD24 Billion 36
  • 6.2 Debt Offerings 39
    • 6.2.1 Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028 39
  • 6.3 Equity Offerings 41
    • 6.3.1 Corindus Vascular Robotics to Raise USD25 Million in Private Placement of Preferred Shares and Warrants 41
    • 6.3.2 BioSig Technologies Raises USD4.5 Million in Private Placement of Shares 43
    • 6.3.3 MC10 Raises Funds through Private Placement of Shares 44
    • 6.3.4 MRI Interventions Raises USD13.3 Million in Private Placement of Units 45
    • 6.3.5 BioSig Technologies Raises USD4.3 Million in Private Placement of Shares 47
  • 6.4 Venture Financing 48
    • 6.4.1 MC10 Raises USD15 Million in Venture Financing 48
    • 6.4.2 BioSig Technologies Raises USD2 Million in Venture Financing 49
    • 6.4.3 MC10 Raises Additional USD2 Million in Venture Financing 50
    • 6.4.4 MC10 Raises USD7.3 Million in Venture Financing 51
    • 6.4.5 BioSig Technologies Raises USD1.6 Million in Venture Financing 52

7 Recent Developments 53

  • 7.1 Corporate Communications 53
    • 7.1.1 Mar 05, 2018: AblaCor Appoints Lawrence Rosenthal To Its Scientific Advisory Board 53
    • 7.1.2 Feb 20, 2018: AtriCure Names Scott Drake Board Chairman 53
    • 7.1.3 Feb 12, 2018: Integer Elects James Hinrichs to its Board of Directors 53
    • 7.1.4 Jan 03, 2018: BioSig Technologies Appoints New CFO to Facilitate Growth Trajectory 54
    • 7.1.5 Jan 02, 2018: Integer Names Kirk Thor Chief Human Resources Officer 54
    • 7.1.6 Nov 14, 2017: BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission 55
    • 7.1.7 Nov 10, 2017: IP veteran Andrew Filler joins BioSig Technologies' Board of Directors 55
    • 7.1.8 Oct 25, 2017: Harvard Bioscience Appoints Katherine Eade and Thomas Loewald to the Board of Directors 56
    • 7.1.9 Oct 11, 2017: BioSig Technologies Welcomes Joseph W. Rafferty as Chief Commercialization Officer 56
    • 7.1.10 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 57
    • 7.1.11 Sep 11, 2017: An opportunity to evaluate and speed-up new projects - Meet GE Healthcare at the Uppsala BIO booth 57
    • 7.1.12 Aug 08, 2017: John K. Bakewell Joins Corindus Vascular Robotics Board of Directors 58
    • 7.1.13 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 58
    • 7.1.14 Jul 18, 2017: AtriCure Announces Hiring of Chief Technology Officer 58
    • 7.1.15 Jul 17, 2017: Integer Announces Appointment of Joseph W. Dziedzic as President and Chief Executive Officer 59
    • 7.1.16 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 60
    • 7.1.17 Jun 07, 2017: Harvard Bioscience Elects James Green as Chairman of Board of Directors 60
    • 7.1.18 May 31, 2017: BioSig Technologies Welcomes Natasha Russkina as Managing Director, Europe 61
    • 7.1.19 May 26, 2017: Merit Medical Announces Appointment of New Director 61
  • 7.2 Financial Announcements 62
    • 7.2.1 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 62
    • 7.2.2 Mar 14, 2018: Corindus Reports Fourth Quarter and Full Year 2017 Results 63
    • 7.2.3 Mar 06, 2018: Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results 64
    • 7.2.4 Feb 26, 2018: AtriCure Announces Fourth Quarter and Full Year 2017 Financial Results 65
    • 7.2.5 Feb 22, 2018: Integer Holdings Reports Results for Fourth Quarter and Full Year 2017 66
    • 7.2.6 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 67
    • 7.2.7 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 68
    • 7.2.8 Jan 08, 2018: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017 69
    • 7.2.9 Jan 08, 2018: Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results 69
    • 7.2.10 Nov 09, 2017: Stereotaxis Reports Third Quarter 2017 Financial Results 69
    • 7.2.11 Nov 07, 2017: Corindus Vascular Robotics Reports Third Quarter 2017 Results 70
    • 7.2.12 Nov 01, 2017: AtriCure Reports Third Quarter 2017 Financial Results 71
    • 7.2.13 Oct 26, 2017: Harvard Bioscience Reports Third Quarter 2017 Financial Results 72
    • 7.2.14 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 73
    • 7.2.15 Oct 26, 2017: Integer Holdings Reports Third Quarter 2017 Results 74
    • 7.2.16 Oct 25, 2017: Bard Announces Third Quarter Results 75
    • 7.2.17 Oct 25, 2017: Merit Medical Reports Results for Third Quarter 2017 76
    • 7.2.18 Oct 16, 2017: Kura Oncology Announces Late-Breaking Presentations for Tipifarnib in HRAS Mutant Squamous Head and Neck Cancer at Upcoming AACR-NCI-EORTC International Conference 77
    • 7.2.19 Sep 26, 2017: DFB Soria Gives Update on Enrollment in Phase 2 Clinical Trial of SOR007 (Nanoparticle Paclitaxel) Ointment for Actinic Keratosis (AK) 78
    • 7.2.20 Sep 09, 2017: Teva Showcases Data Demonstrating Potential of Fremanezumab to Address Significant Unmet Need in Patients with Chronic and Episodic Migraine 79
    • 7.2.21 Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results 81
    • 7.2.22 Aug 08, 2017: Corindus Vascular Robotics Reports Second Quarter 2017 Results 82
    • 7.2.23 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 83
    • 7.2.24 Jul 27, 2017: AtriCure Reports Second Quarter 2017 Financial Results 84
    • 7.2.25 Jul 27, 2017: Harvard Bioscience Reports Second Quarter 2017 Financial Results 84
    • 7.2.26 Jul 27, 2017: Integer Holdings Reports Second Quarter 2017 Results 85
    • 7.2.27 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance 86
    • 7.2.28 May 09, 2017: Corindus Vascular Robotics Reports First Quarter 2017 Results 87
    • 7.2.29 May 08, 2017: Integer Holdings Reports First Quarter 2017 Results 88
    • 7.2.30 May 08, 2017: Stereotaxis Reports 2017 First Quarter Financial Results 89
    • 7.2.31 May 04, 2017: AtriCure Reports First Quarter 2017 Financial Results 89
    • 7.2.32 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 90
    • 7.2.33 Apr 27, 2017: Harvard Bioscience Reports First Quarter 2017 Financial Results 91
    • 7.2.34 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 91
    • 7.2.35 Apr 23, 2017: Bard Announces First Quarter Results 92
    • 7.2.36 Apr 17, 2017: Lixte Biotechnology's Protein Phosphatase 2A Inhibitor, LB-100, Reported to be a Potentiator of Immunotherapy in an Animal Model 93
  • 7.3 Other Significant Developments 94
    • 7.3.1 Mar 06, 2018: V ClinBio Partners with Camargo for Strategic 505(b)(2) Development of CLX-103 94
    • 7.3.2 Feb 22, 2018: Integer Announces Strategy Focused on Portfolio Management and Operational Excellence; Aligns Senior Management to Execute Strategic Imperatives 95
    • 7.3.3 Dec 21, 2017: BioSig Technologies Issues Shareholder Letter for 2017 96
    • 7.3.4 Nov 02, 2017: BioSig Technologies Partners with Sherpa Technology Group 96
    • 7.3.5 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 97
    • 7.3.6 Jun 01, 2017: Hitachi Healthcare Americas Partners with the WVU Heart and Vascular Institute to Advance the Evaluation of Left Ventricular Mechanical Function 98
  • 7.4 Strategy And Business Planning 99
    • 7.4.1 Nov 20, 2017: DBV Technologies Announces Positive Topline Safety Results from REALISE Phase III Trial of Viaskin Peanut for the Treatment of Peanut-Allergic Patients 99
    • 7.4.2 Sep 11, 2017: An opportunity to evaluate and speed-up new projects - Meet GE Healthcare at the Uppsala BIO booth 100

8 Appendix 102

  • 8.1 Research Methodology 103
    • 8.1.1 Coverage 103
    • 8.1.2 Secondary Research 103
    • 8.1.3 Primary Research 104
    • 8.1.4 Market Modeling and Forecasting 105
    • 8.1.5 Company Share Analysis 106
    • 8.1.6 Distribution Share Analysis 107
    • 8.1.7 Benchmarking 107
  • 8.2 GlobalData Consulting 107
  • 8.3 Contact Us 108
  • 8.4 Disclaimer 108

List of Tables

1.1 List of Tables

  • Table 1: Electrophysiology Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 10
  • Table 2: Electrophysiology Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 10
  • Table 3: Electrophysiology Ablation Catheters Market, United States, Revenue ($m), USD Constant, 2015-2020 12
  • Table 4: Electrophysiology Ablation Catheters Market, United States, Revenue ($m), USD Constant, 2021-2025 12
  • Table 5: Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), USD Constant, 2015-2020 14
  • Table 6: Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), USD Constant, 2021-2025 14
  • Table 7: Electrophysiology Lab Systems Market, United States, Revenue ($m), USD Constant, 2015-2020 16
  • Table 8: Electrophysiology Lab Systems Market, United States, Revenue ($m), USD Constant, 2021-2025 17
  • Table 9: Electrophysiology Devices Market, United States, Volume (Units), 2015-2020 19
  • Table 10: Electrophysiology Devices Market, United States, Volume (Units), 2021-2025 19
  • Table 11: Electrophysiology Ablation Catheters Market, United States, Volume (Units), 2015-2020 21
  • Table 12: Electrophysiology Ablation Catheters Market, United States, Volume (Units), 2021-2025 21
  • Table 13: Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), 2015-2020 23
  • Table 14: Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), 2021-2025 23
  • Table 15: Electrophysiology Lab Systems Market, United States, Volume (Units), 2015-2020 25
  • Table 16: Electrophysiology Lab Systems Market, United States, Volume (Units), 2021-2025 26
  • Table 19: Electrophysiology Devices Market, United States, Average Price ($), 2015-2020 27
  • Table 20: Electrophysiology Devices Market, United States, Average Price ($), 2021-2025 28
  • Table 21: Electrophysiology Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 29
  • Table 22: Electrophysiology Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2017 31
  • Table 23: Electrophysiology Devices Market Pipeline Products 34
  • Table 24: NN Acquires Bridgemedica 35
  • Table 25: Becton, Dickinson Acquires C. R. Bard for USD24 Billion 36
  • Table 26: Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028 39
  • Table 27: Corindus Vascular Robotics to Raise USD25 Million in Private Placement of Preferred Shares and Warrants 41
  • Table 28: BioSig Technologies Raises USD4.5 Million in Private Placement of Shares 43
  • Table 29: MC10 Raises Funds through Private Placement of Shares 44
  • Table 30: MRI Interventions Raises USD13.3 Million in Private Placement of Units 45
  • Table 31: BioSig Technologies Raises USD4.3 Million in Private Placement of Shares 47
  • Table 32: MC10 Raises USD15 Million in Venture Financing 48
  • Table 33: BioSig Technologies Raises USD2 Million in Venture Financing 49
  • Table 34: MC10 Raises Additional USD2 Million in Venture Financing 50
  • Table 35: MC10 Raises USD7.3 Million in Venture Financing 51
  • Table 36: BioSig Technologies Raises USD1.6 Million in Venture Financing 52
  • Table 44: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 105

List of Figures

1.2 List of Figures

  • Figure 1: Electrophysiology Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 9
  • Figure 2: Electrophysiology Ablation Catheters Market, United States, Revenue ($m), USD Constant, 2015-2025 11
  • Figure 3: Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), USD Constant, 2015-2025 13
  • Figure 4: Electrophysiology Lab Systems Market, United States, Revenue ($m), USD Constant, 2015-2025 15
  • Figure 5: Electrophysiology Devices Market, United States, Volume (Units), 2015-2025 18
  • Figure 6: Electrophysiology Ablation Catheters Market, United States, Volume (Units), 2015-2025 20
  • Figure 7: Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), 2015-2025 22
  • Figure 8: Electrophysiology Lab Systems Market, United States, Volume (Units), 2015-2025 24
  • Figure 9: Electrophysiology Devices Market, United States, Company Share (%) 2017 30
Back to Top